BACKGROUND CONTEXT A previous study by Pellisé et al identified strong preoperative and surgical predictors of major complications. It is unknown which of these risk factors has the most significant impact on cost-effectiveness. PURPOSE To assess the impact of previously established risk factors on the cost effectiveness of ASD surgery. STUDY DESIGN/SETTING Retrospective. PATIENT SAMPLE A total of 689 ASD patients. OUTCOME MEASURES Quality adjusted life years (QALYs), utility gained, ODI, total cost. METHODS ASD patients with baseline (BL) and 2-year postoperative (2Y) data were included. Frailty score, sagittal deformity measures (SVA, PI-LL, T1 Sagittal Tilt), blood loss and surgical time were divided into tertiles, with the highest tertile being classified as high risk. Since some patients have multiple risk factors, they may be included in multiple groups. Descriptive analysis identified demographics, radiographic parameters and surgical factors. Published methods for cost was calculated using the PearlDiver database and CMS.gov definitions. Cost per QALY at 2Y was calculated for each risk factor. RESULTS There were 422 patients included. Of the 381 patients with a risk factor, 77% were fused to the pelvis, 44% were highly frail, 56% had a high deformity, 34% had high EBL and 34% had high operative time. When analyzing BL scores, highly frail patients had the highest mean ODI and EQ-5D. After undergoing surgery, patients with a high EBL had the highest rate of SICU admissions, rate of any complications and rate of major complications. This translated to patients with high EBL having the lowest utility gained at 2Y. Interestingly, patients with high frailty had the highest rates of implant complications and pseudarthrosis resulting in the second highest major complication rates and total estimated cost. Despite this high estimated cost, however, patients with high frailty also achieved the highest utility gained at 2Y resulting in the best cost-utility at two years. CONCLUSIONS Despite having higher rates of implant failures, pseudarthrosis, and major complications, highly frail patients managed to generate the highest utility gained and best cost-effectiveness, while higher blood loss had higher rates of complications as well, but demonstrated the lowest utility gained and cost-utility. Therefore, spine surgeons should limit intraoperative risk factors, such as blood loss and operative time, which would minimize postoperative complications and improve overall cost-effectiveness during correction of adult spinal deformity. FDA DEVICE/DRUG STATUS This abstract does not discuss or include any applicable devices or drugs. A previous study by Pellisé et al identified strong preoperative and surgical predictors of major complications. It is unknown which of these risk factors has the most significant impact on cost-effectiveness. To assess the impact of previously established risk factors on the cost effectiveness of ASD surgery. Retrospective. A total of 689 ASD patients. Quality adjusted life years (QALYs), utility gained, ODI, total cost. ASD patients with baseline (BL) and 2-year postoperative (2Y) data were included. Frailty score, sagittal deformity measures (SVA, PI-LL, T1 Sagittal Tilt), blood loss and surgical time were divided into tertiles, with the highest tertile being classified as high risk. Since some patients have multiple risk factors, they may be included in multiple groups. Descriptive analysis identified demographics, radiographic parameters and surgical factors. Published methods for cost was calculated using the PearlDiver database and CMS.gov definitions. Cost per QALY at 2Y was calculated for each risk factor. There were 422 patients included. Of the 381 patients with a risk factor, 77% were fused to the pelvis, 44% were highly frail, 56% had a high deformity, 34% had high EBL and 34% had high operative time. When analyzing BL scores, highly frail patients had the highest mean ODI and EQ-5D. After undergoing surgery, patients with a high EBL had the highest rate of SICU admissions, rate of any complications and rate of major complications. This translated to patients with high EBL having the lowest utility gained at 2Y. Interestingly, patients with high frailty had the highest rates of implant complications and pseudarthrosis resulting in the second highest major complication rates and total estimated cost. Despite this high estimated cost, however, patients with high frailty also achieved the highest utility gained at 2Y resulting in the best cost-utility at two years. Despite having higher rates of implant failures, pseudarthrosis, and major complications, highly frail patients managed to generate the highest utility gained and best cost-effectiveness, while higher blood loss had higher rates of complications as well, but demonstrated the lowest utility gained and cost-utility. Therefore, spine surgeons should limit intraoperative risk factors, such as blood loss and operative time, which would minimize postoperative complications and improve overall cost-effectiveness during correction of adult spinal deformity.